Popular Articles
Natural Remedies

Finding Key To Cancer Drug Gleevec's Limitations
University of Michigan researchers have developed an animal model that provides strong evidence why imatinib, marketed as Gleevec, helps patients with chronic myeloid leukemia survive longer, but does not keep the disease from returning if treatment ends.
generic viagra online
New Cellular Targets For HIV Drug Development Suggested By Research
Focusing HIV drug development on immune cells called macrophages instead of traditionally targeted T cells could bring us closer to eradicating the disease, according to new research from University of Florida and five other institutions.
News of the day
Flu Shot May Be Less Effective After Transplant
Kidney transplant patients have a weaker response to influenza immunization than healthy individuals, especially in the first six months after receiving a transplant, according to a study published in the July issue of the American Journal of Kidney Diseases, the official journal of the National Kidney Foundation.
Endocrinology

CBO: Health Reform Bills Bend Cost Curve In Wrong Direction

"Congress"s chief budget analyst delivered a devastating assessment yesterday of the health-care proposals drafted by congressional Democrats, fueling an insurrection among fiscal conservatives in the House and pushing negotiators in the Senate to redouble efforts to draw up a new plan that more effectively restrains federal spending," the Washington Post reports. President Obama and congressional Democrats have said bending the "cost curve" of health care spending is a priority in health reform, to ensure soaring costs don"t become unsustainable. Douglas Elmendorf, the director of the Congressional Budget Office, told lawmakers yesterday that bills proposed by the Senate health committee and the House leadership do the opposite: "The curve is being raised" (Montgomery and Murray, 7/17). "In the legislation that has been reported, we do not see the sort of fundamental changes that would be necessary to reduce the trajectory of federal health spending by a significant amount and, on the contrary, the legislation significantly expands the federal responsibility for health care costs," Elmendorf said, according to CQ Politics. Ways to reduce the rate of growth could include taxing employer-provided health benefits and reforming Medicare payments to reward cost effectiveness, rather than volume (Clarke and Epstein, 7/16). The Senate"s No. 2 Democrat, Richard Durbin, D-Ill., retorted that Elmendorf has "taken unrealistic positions" on the health care debate, and has failed to score important cost savings from measures for things like preventive care, the Wall Street Journal reports. "It"s been really hard to work with them." Meanwhile, the Republican leadership embraced Elmendorf"s comments. "The director of the Congressional Budget Office confirmed today what we have been saying for weeks: The health-care-spending plan that some are trying to rush through Congress would actually make things worse," said Senate Minority Leader Mitch McConnell (Boles, 7/16). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):